15/01/2024 BlogNewsStem Cell NewsUses for Cord Blood
Stem Cell Blog
Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.
15/01/2024 BlogStem Cell NewsUses for Cord Blood
In an exciting new development within the stem cell field, a man from London has become the second patient in the world to be cured of HIV following a stem cell treatment.
Alongside being diagnosed with HIV in 2003, Adam Castillejo was also later diagnosed with Hodgkin’s lymphoma in 2012 – an extremely rare form of blood cancer. Shortly after, Adam, also known as the “London Patient”, began to receive traditional medication in an attempt to treat the cancer.
15/01/2024 BlogNewsStem Cell NewsUses for Cord Blood
Cells4Life is proud to announce our membership of the All-Party Parliamentary Group for Longevity (APPG). Our aim is to deliver 5 extra years of healthy life expectancy to all British citizens by 2035 while minimising health inequalities. Regenerative medicine will be crucial to achieving this objective.
09/01/2024 BlogNewsStem Cell NewsUses for Cord Blood
In the past year, potential stem cell uses have rapidly increased and the number of stem cell clinical trials has grown from 6,500 to 7,255. Just in the first half of 2019, there have been impressive developments in regenerative medicine – including a one-year-old boy cured of cancer, and the possibility of a cure for HIV.
09/01/2024 BlogStem Cell NewsUses for Cord Blood
Scientists at Duke University, North Carolina have begun investigating the effect of cord blood on sufferers of adult stroke.
100 patients between 18-90 years of age will undergo umbilical cord blood transfusions between 3 and 10 days after their stroke. They will then be monitored for results.
09/01/2024 BlogStem Cell NewsUses for Cord Blood
A new study published by the University of Pittsburgh School of Medicine suggests cord blood could extend the lives of children with Krabbe disease.
Research, led by Dr Maria Escolar, showed that cord blood transfusions not only improved life expectancy for patients, but also increased quality of life.
09/01/2024 BlogStem Cell NewsUses for Cord Blood
In the USA, the Food & Drug Authority (FDA) has given permission to Duke University Medical Center to offer cord blood therapy to children with neurological conditions including:
09/01/2024 BlogNewsOtherStem Cell News
At Cells4Life, we are always keen to share encouraging developments in the field of regenerative medicine. Today, we bring you an exciting update from Bayer’s (OTC:BAYRY) subsidiary BlueRock, who have reported initial success in treating Parkinson’s disease in experimental stem cell therapy.
09/01/2024 BlogOtherStem Cell News
A Phase II trial investigating the use of umbilical cord blood mesenchymal stem cells (MSCs) to treat bronchopulmonary dysplasia (BPD) in premature infants has shown promising initial results, giving way to a larger Phase II study, focusing on a subset of babies who looked to have benefitted most from the therapy.
08/01/2024 BlogNewsPregnancy AdviceStem Cell News
To kick off the new year, we’ve taken a look back at some of the many cord blood developments of 2018 and a look forward to what 2019 could hold. Here is our stem cell timeline…
Cells4Life Group LLP,
Units 2-3 Oak House, Woodlands Office Park,
Albert Drive, Burgess Hill, RH15 9TN, UK.
Med Bio Genetics
Pero Nakov 110, Skopje, Republic Macedonia
+389 70 221 602
info@cells4life.mk
Cells4Life Blog Posts
12/02/2026
